An accurate, even-handed guide to occupational glyphosate exposure in 2026: who is exposed, the genuine scientific debate over non-Hodgkin lymphoma, safe handling, PPE and re-entry intervals, the Bayer litigation as factual context, and an honest look at how claims work.
Few workplace chemicals are as common, or as fiercely argued about, as glyphosate. It is the world's most widely used herbicide, sprayed on farms, lawns, golf courses, roadsides and rail corridors, and sold under Roundup and dozens of other names. For most of its history it was regarded as one of the safer weedkillers. Then, in 2015, a major cancer agency flagged a possible link to a type of lymphoma — and the same evidence was read very differently by regulators. The result is a topic where headlines, courtrooms and scientists genuinely disagree. This guide tries to do something the loudest voices often do not: lay out both sides fairly, focus on the workers actually exposed, and give practical, non-promotional guidance on protecting yourself and understanding your options.
Glyphosate is a broad-spectrum, systemic herbicide. It kills most green plants by blocking an enzyme (EPSP synthase) in a metabolic pathway that plants need but that humans and animals do not have — one reason it was long considered relatively low-hazard to people compared with older pesticides. It was introduced commercially in the 1970s and its use exploded after the arrival of "Roundup Ready" genetically modified crops engineered to survive being sprayed.
Roundup is simply the best-known brand of glyphosate-based weedkiller. It was developed by Monsanto, which was acquired by Bayer in 2018; glyphosate itself is off-patent and now sold by many manufacturers as branded and generic products. An important and often-missed point: commercial formulations are not pure glyphosate. They are mixtures of glyphosate, surfactants (which help the spray stick to and penetrate leaves) and other co-formulants. Some of the scientific debate is about whether the formulated product behaves differently from glyphosate tested alone — a distinction that matters when interpreting studies.
This is the heart of the matter, and it deserves to be presented straight rather than spun. The central question is whether glyphosate causes cancer in people — specifically non-Hodgkin lymphoma (NHL), a cancer of the lymphatic system. Credible scientific bodies have reached genuinely different conclusions.
In March 2015 the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as "probably carcinogenic to humans," its Group 2A. IARC pointed to limited evidence in humans for non-Hodgkin lymphoma, sufficient evidence of cancer in laboratory animals, and evidence that glyphosate can damage DNA and cause oxidative stress. It is crucial to understand what Group 2A actually means: IARC assesses hazard — whether a substance is capable of causing cancer under some circumstances — not how likely harm is at real-world doses. The same 2A category includes things like red meat and very hot beverages, which tells you the label describes strength of evidence, not magnitude of everyday risk.
Regulators reached the opposite practical conclusion. The US Environmental Protection Agency (EPA) has concluded that glyphosate is "not likely to be carcinogenic to humans" at the doses relevant to its approved uses, and that there are no other meaningful human health risks when it is used according to the label. The European Food Safety Authority (EFSA), working with EU member-state experts, similarly concluded that glyphosate does not meet the criteria to be classified as carcinogenic. These bodies assess risk — whether harm is likely at actual exposure levels — and they reviewed a broader set of regulatory studies, including unpublished industry data, alongside the published literature.
It is tempting to assume one side must be lying or incompetent. A more honest reading is that hazard and risk are different questions, and the two camps used different frameworks and different evidence sets. IARC asks "can this cause cancer at all?" and weights published, independent studies. The EPA and EFSA ask "is this likely to cause cancer the way it is actually used?" and include the full regulatory dossier. Reasonable scientists also disagree about how to weigh certain studies, the role of the surfactants in formulations, and how to interpret mixed epidemiology. Some large studies of agricultural workers have not found a clear glyphosate–NHL link; others suggest a possible association at the highest exposures. The defensible bottom line for a worker is simple: the question is not settled, the most likely effect (if any) is at heavy, repeated, poorly protected exposure, and it makes sense to minimise your exposure while the science continues. That is a precautionary stance, not a verdict.
Glyphosate exposure is overwhelmingly an occupational and applicator story. The general public's contact through trace food residues is tiny; the people with meaningful exposure are those who handle and apply it, often for years. Exposure is highest during mixing and loading the concentrate and during application without proper protection — not from the dilute spray drifting past once.
| Worker group | Why the exposure |
|---|---|
| Farmworkers & agricultural applicators | Mix, load and spray glyphosate across large acreages, often repeatedly through the season. |
| Commercial & residential landscapers | Use glyphosate routinely for weed control on client properties, frequently with backpack sprayers. |
| Groundskeepers & parks crews | Maintain large turf, beds and hardscapes; high frequency of hands-on application. |
| Golf-course turf crews | Regular vegetation management across fairways, roughs and surrounds. |
| Nursery & greenhouse workers | Apply herbicide in enclosed or semi-enclosed spaces and handle treated stock. |
| Roadside, rail & utility vegetation crews | Spray rights-of-way, verges and substations, sometimes at high volumes. |
| Pesticide applicators generally | Licensed and unlicensed applicators across many sectors who handle concentrate. |
The famous Roundup lawsuits largely involve groundskeepers and home/agricultural users with years of repeated, hands-on contact — the pattern that matters most for any exposure concern. Brief, incidental contact with a properly diluted, label-applied product is a very different situation from decades of mixing concentrate without gloves.
Whatever one believes about the cancer question, reducing exposure is sensible, cheap and required by law when you use a product against its label. In the United States the pesticide label is a legal document — using a product in a way the label prohibits is a violation, and the label's personal-protective-equipment, mixing and re-entry instructions are mandatory, not advisory.
Always follow the specific product label, but typical glyphosate PPE includes:
Most applicator exposure happens not while spraying the diluted product but while handling the undiluted concentrate during mixing and loading. Pour at low height to avoid splashing, use closed mixing or transfer systems where available, never eat, drink, smoke or touch your face with contaminated gloves, and wash up thoroughly afterwards. Do not spray in windy conditions, which causes drift and self-contamination, and keep the spray downwind of yourself.
The EPA's Worker Protection Standard (WPS) governs agricultural pesticide use and sets the restricted-entry interval (REI) — the time that must pass after application before people may enter the treated area without PPE, allowing residues to decline. Re-entering too early, or without the required protection, is a common and entirely avoidable source of exposure. Track the REI on every job, post treated areas, and provide training, decontamination water and emergency information as the WPS requires. After any work with glyphosate, change out of work clothing, launder it separately from household laundry, and wash your hands and skin before eating or going home so residues do not travel with you.
The legal story is part of why people search for this topic, so here are the facts, plainly and without taking a side. Beginning in the late 2010s, tens of thousands of people in the United States sued Monsanto, and then Bayer after its acquisition, alleging that Roundup exposure caused their non-Hodgkin lymphoma and that the maker failed to warn of the risk. Several early jury trials returned large verdicts for plaintiffs, although some awards were later reduced or are still being contested on appeal.
In 2020 Bayer agreed to pay roughly $10–11 billion to settle a large portion of the existing claims, while continuing to state that glyphosate is safe and not carcinogenic and that it stands behind the regulatory science. Litigation did not end there: new cases have continued to be filed and tried, with mixed results — some juries siding with plaintiffs, others with Bayer — and ongoing appellate questions about whether federal pesticide law preempts state "failure to warn" claims. These are simply events that have happened. A settlement is a business and legal decision; it is not the same as a scientific finding of causation, just as a regulator's approval is not proof of harmlessness. We name no law firm and earn nothing from any claim.
If you have used glyphosate heavily over many years, the responsible approach is measured, not fearful. Non-Hodgkin lymphoma is an uncommon disease, and most exposed workers will never develop it — and, as above, whether glyphosate causes it at all is debated. The sensible steps are practical:
There is no routine population screening test for glyphosate-related disease, so the priority is an informed physician and attention to symptoms, not self-testing or alarm.
If someone is diagnosed with a disease they believe is linked to occupational glyphosate exposure, a few avenues may exist. The aim here is accuracy, not pushing anyone toward a particular firm or outcome — and the heavy advertising around this topic is exactly why a neutral summary is useful.
Several honest caveats matter here. Causation in an individual case is contested precisely because the underlying science is debated, so no honest source can promise an outcome. Time limits are real and can bar a valid claim if missed. Beware advertising that presents the cancer link as settled fact or guarantees a payout — it is neither settled nor guaranteed. The right sequence is medical first, legal second: get an accurate diagnosis from a qualified physician, and only then, if appropriate, consult a licensed attorney of your own choosing about your specific situation. AEGIS - AMA provides no legal services, refers to no law firm, recommends no product, and earns nothing from any claim.
These free, no-signup tools run entirely in your browser and connect to the wider topic of chemical and pesticide exposure at work:
What is glyphosate and what is Roundup?
Glyphosate is a broad-spectrum herbicide that kills most plants by blocking an enzyme they need to grow. Roundup is the best-known brand of glyphosate-based weedkiller, originally developed by Monsanto and now owned by Bayer, though glyphosate is also sold under many other brand and generic names. Commercial products are mixtures of glyphosate plus surfactants and other ingredients, not glyphosate alone.
Does glyphosate cause cancer?
This is genuinely disputed. In 2015 the International Agency for Research on Cancer (IARC) classified glyphosate as probably carcinogenic to humans (Group 2A), citing a possible link to non-Hodgkin lymphoma. The US Environmental Protection Agency (EPA) and the European Food Safety Authority (EFSA) reviewed the evidence and concluded glyphosate is not likely to be carcinogenic to humans at expected exposure levels. Both conclusions come from credible bodies, so the honest answer is that the question is not settled.
Why do IARC and the EPA disagree about glyphosate?
They ask different questions and weigh evidence differently. IARC assesses hazard, meaning whether something can cause cancer under some conditions, and leans heavily on published studies. The EPA and EFSA assess risk, meaning whether harm is likely at real-world exposure levels, and include a wider body of regulatory and unpublished industry studies. The two frameworks can reach different answers about the same chemical without either being simply wrong.
Which workers are most exposed to glyphosate?
The most exposed are people who mix, load and apply glyphosate frequently: farmworkers and agricultural applicators, commercial and residential landscapers, groundskeepers, golf-course and parks crews, nursery and greenhouse workers, vegetation-control crews for roads, rail and utilities, and pesticide applicators generally. Exposure is highest during mixing and loading of concentrate and when working without proper protective equipment.
What PPE should I wear when using glyphosate?
Always follow the product label, which is legally binding in the United States. Typical protection includes chemical-resistant gloves, long-sleeved shirt and long pants, shoes plus socks, and eye protection, with additional protection such as a respirator, apron or coveralls for mixing concentrate or for certain tasks. Gloves are the single most important item because hands receive the most contact during mixing and loading.
What is a restricted-entry interval and why does it matter?
A restricted-entry interval (REI) is the time that must pass after a pesticide is applied before workers may enter the treated area without protective equipment. It is set on the label under the EPA Worker Protection Standard to let residues decline. Re-entering too soon, or without the required PPE, is a common and avoidable source of exposure, so the REI should be tracked and enforced on every job.
How can I reduce my glyphosate exposure at work?
Read and follow the label, wear the specified PPE, and take extra care during mixing and loading where exposure is highest. Use closed mixing systems or careful pouring to avoid splashes, do not spray in windy conditions, wash hands before eating, drinking or using the toilet, change out of contaminated clothing and launder it separately, and follow the restricted-entry interval. Good hygiene and label compliance prevent most exposure.
What is the Roundup litigation and the Bayer settlement?
Tens of thousands of people in the United States have sued Bayer (which bought Monsanto, the original maker of Roundup) alleging that Roundup exposure caused their non-Hodgkin lymphoma. Bayer agreed in 2020 to pay roughly ten to eleven billion dollars to resolve much of the litigation, while continuing to maintain that glyphosate is safe and not carcinogenic. Litigation has continued, with mixed verdicts in individual cases. These are factual events, not an endorsement of any claim or law firm.
I used Roundup at work for years. Should I be worried?
Try not to panic, but do take it seriously. Most people exposed to glyphosate do not develop non-Hodgkin lymphoma, which is an uncommon disease, and the science on whether glyphosate causes it is genuinely debated. The sensible steps are to tell your physician about your exposure history, watch for symptoms such as persistent swollen lymph nodes, unexplained weight loss, fever or night sweats, and improve your handling and PPE going forward.
Should I see a doctor or a lawyer?
If you are concerned about your health, see a physician first. A doctor can evaluate symptoms, take your exposure history and arrange any appropriate tests. Only if you have been diagnosed with a disease you believe is linked to exposure does a legal consultation become relevant, and then with a licensed attorney of your own choosing. Legal claims are time-sensitive and the rules vary by state, so do not rely on advertising for medical or legal facts.
Disclaimer: This article is general information, not legal or medical advice. The science on glyphosate is genuinely debated — consult a physician and a licensed attorney about your specific situation. Content is written to align with the public guidance of bodies including IARC, the US EPA, EFSA, NIOSH and the CDC; the science and the law continue to evolve and figures change, so confirm current requirements and findings for your jurisdiction. AEGIS - AMA is independent, provides no legal services, refers to no law firm, and recommends no product.